Drug GMP Report
August 2012
Supply Chain Risk Management Standard to Address Pharma Compliance Concerns
A planned, first-of-its-kind, U.S. standard on supply chain risk management will include input from a handful of drugmakers to highlight the impact that compliance lapses have on supply chain security, says the chair of a newly formed industrywide panel developing the standard.
This article is viewable by subscribers only. To view this article, please select an option below.
|